Concepedia

Publication | Open Access

Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical Trial

DOIFull Paper Access

25

Citations

31

References

2022

Year

Duilio Pagano, Jaime Bosch, Fabio Tuzzolino, Elisabetta Oliva, Burcin Ekser, Giovanni Zito, Davide Cintorino, Fabrizio di Francesco, Sergio Li Petri, Calogero Ricotta,
Transplantation

Abstract

Donor simvastatin treatment is safe, and may significantly improve early graft and patient survival after liver transplantation, although further research is mandatory.

References

YearCitations

Page 1